Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Pfizer Must Pay $1.5 Million in Prempro Damages, Jury in Puerto Rico Says
Bloomberg
Sunday, January 2, 2011 - 12:12pm
tags:
Pfizer, Prempro, lawsuits
GlaxoSmithKline Passes This Key Test
Motley Fool
Sunday, January 2, 2011 - 12:11pm
tags:
GSK
Pharma Ups the Dividend Ante
Motley Fool
Sunday, January 2, 2011 - 12:10pm
tags:
investors
BioSante Pharmaceuticals Closes $18 Million Registered Direct Offering to Fund LibiGel® for Female Sexual Dysfunction
Yahoo/BusinessWire
Sunday, January 2, 2011 - 11:38am
tags:
LibiGel, female sexual dysfunction, BioSante
3 Biotech 2010 IPOs Worthy of a Look
Motley Fool
Sunday, January 2, 2011 - 11:34am
tags:
biotech, Pacific Biosciences, Alimera, Aveo Pharmaceutical, Biogen Idec, tivozanib, kidney cancer, DNA sequencing
Advanced Cell Technology Secures $25 Million Funding Commitment
Yahoo/BusinessWire
Sunday, January 2, 2011 - 11:32am
tags:
Advanced Cell Technologies
WATCH FOR CONTINUED GAINS IN SHARES OF PAR PHARMACEUTICAL
Zacks.com
Sunday, January 2, 2011 - 11:20am
tags:
Par Pharmaceutical, investors
GlaxoSmithKline Passes This Key Test
Motley Fool
Friday, December 31, 2010 - 1:26pm
tags:
GSK
Burrill predicts big surge in biotech buyouts for 2011
Fierce Biotech
Friday, December 31, 2010 - 11:28am
tags:
M&A, biotech
CEL-SCI Investors Cheer a Bit Too Loudly
Motley Fool
Friday, December 31, 2010 - 11:27am
tags:
Cel-Sci, Multikine, head and neck cancer
New Drug Approvals Fall in 2010 as Safety Concerns Slow U.S. FDA Decisions
Bloomberg
Friday, December 31, 2010 - 10:58am
tags:
drug approvals, FDA
This NICE Deal Could Foreshadow 2011
Motley Fool
Friday, December 31, 2010 - 10:55am
tags:
NICE, GSK, Pfizer, Human Genome Sciences, Bristol-Myers Squibb, Merck, AstraZeneca, value-based pricing
That's What You Call Product Differentiation?
Motley Fool
Friday, December 31, 2010 - 10:53am
tags:
testosterone, Endo, Abbott Laboratories, Auxilium, Fortesta, Androgel, Testim
2011 Drugmaker M&A Targets
Motley Fool
Friday, December 31, 2010 - 10:00am
tags:
M&A, Pfizer, Merck, Genzyme, Sanofi, JNJ, Crucell, ONYX Pharmaceuticals, Bayer, Momenta, Novartis, GSK, Human Genome Sciences, Vertex Pharmaceuticals, MannKind, Vivus, Savient
Pfizer Diagnoses Fido, Too
Motley Fool
Friday, December 31, 2010 - 9:58am
tags:
animal health, Pfizer, Synbiotics, M&A
A Look At The Drug Makers Of 2010
Investopedia
Friday, December 31, 2010 - 9:56am
tags:
JNJ, Merck, Novartis, Pfizer, Roche
Exclusive: Glaxo’s Witty On Why He Shuns Megadeals
Forbes
Friday, December 31, 2010 - 9:55am
tags:
GSK, Andrew Witty, M&A, Pharma CEOs
What's Next for Achillion Pharma?
Seeking Alpha
Thursday, December 30, 2010 - 11:31am
tags:
Achillion, Gilead Sciences, Bristol-Myers Squibb
Here We Go Again . . . . Amphastar Renews Generic LOVENOX Case Against FDA
FDA Law Blog
Thursday, December 30, 2010 - 11:15am
tags:
Lovenox, generics, Amphastar, Sanofi
The Next $100 Billion Technology Business
Forbes
Thursday, December 30, 2010 - 11:14am
tags:
DNA sequencing

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.